Introduction:Basic information about N-(2-Hydroxyethyl)adenosine CAS 4338-48-1, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
N-(2-Hydroxyethyl)adenosine Basic information
| Product Name: | N-(2-Hydroxyethyl)adenosine |
| Synonyms: | NSC 54251;(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-di;N-(2-Hydroxyethyl)adenosine;6-Hydroxyethyladenosine;N6-(2-Hydroxyethyl)adenosine;(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)aMino)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol;(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4;Adenosine, N-(2-hydroxyethyl)- |
| CAS: | 4338-48-1 |
| MF: | C12H17N5O5 |
| MW: | 311.29 |
| EINECS: | 200-001-2 |
| Product Categories: | |
| Mol File: | 4338-48-1.mol |
|
N-(2-Hydroxyethyl)adenosine Chemical Properties
| Melting point | 194-195℃ |
| Boiling point | 725.8±70.0 °C(Predicted) |
| density | 1.88 |
| storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 13.11±0.70(Predicted) |
| color | White to Off-White |
| InChI | InChI=1S/C12H17N5O5/c18-2-1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(21)8(20)6(3-19)22-12/h4-6,8-9,12,18-21H,1-3H2,(H,13,14,15)/t6-,8-,9-,12-/m1/s1 |
| InChIKey | BBOCDRLDMQHWJP-WOUKDFQISA-N |
| SMILES | OC[C@H]1O[C@@H](N2C3C(=C(N=CN=3)NCCO)N=C2)[C@H](O)[C@@H]1O |
Safety Information
N-(2-Hydroxyethyl)adenosine Usage And Synthesis
| Uses | N-(2-Hydroxyethyl)adenosine has been studied as an anticonvulsant through the activation of adenosine A1 receptor (AA1R). |
| in vivo | N6-(2-Hydroxyethyl)adenosine (20-40 mg/kg, ip, once daily for 6 weeks) reduces the blood glucose level and diabetes-induced kidney damage, increases the activities of antioxidant enzymes (such as SOD, catalase CAT and GSH) in renal tissue, reduces the level of malondialdehyde (MDA), exhibits anti-inflammatory and antioxidant activities, and ameliorates Alloxan (HY-W017227)-induced diabetes in rats models[2]. N6-(2-Hydroxyethyl)adenosine (75-150 mg/kg, po, once daily for 19 days) exhibits antitumor effect in SGC-7901 xenograft mouse models[4].
| Animal Model: | Alloxan-induced diabetes in rats models[2] | | Dosage: | 20-40 mg/kg | | Administration: | ip, once daily for 6 weeks | | Result: | Reduced the levels of blood glucose, serum creatinine (Scr), blood urea nitrogen (BUN) and urine protein. Reduced the levels of TNF-α, IL-1β, IL-6, TGF-β1 and NF-κB in kidney tissue. Alleviated the damage of glomeruli and renal tubules.
| Animal Model: | SGC-7901 xenograft mouse models[4] | | Dosage: | 75-150 mg/kg | | Administration: | po, once daily for 19 days | | Result: | Reduced tumor volume and weight. |
| N-(2-Hydroxyethyl)adenosine Preparation Products And Raw materials| Raw materials | 6-(BETA-HYDROXYETHYLAMINO)-PURINE-->6-Hydroxypurine-->Inosine |
|